Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. chil. cir ; 62(6): 587-593, dic. 2010. ilus
Article in Spanish | LILACS | ID: lil-577305

ABSTRACT

Background: Two stage hepatectomy takes advantage of the compensatory regeneration of the liver after a first non curative hepatectomy, to achieve a curative excision in a second intervention. Aim: To report an initial experience with two stage hepatectomy. Material and Methods: Out of sixty four patients who underwent hepatectomy in our institution in the presented period, eight met criteria for colorectal primary and bilateral liver metastatic disease, which we report. Results: Eight patients were subjected to a right portal ligation. In four, a simultaneous metastasis excision in the left lobe was performed. Four to eight weeks later, five were subjected to a right hepatectomy. One patient, that had a relapse of a previous hepatectomy and colectomy, was explored, ligated and afterwards subjected to surgery plus radiofrequency. The six patients that were subjected to excisions were followed for 3 to 39 months. One patient died due to massive pulmonary relapse at 18 months, two were operated again and subjected to radiofrequency, without evidence of residual disease. Two patients have no evidence of relapse and one had a relapse in a rib. Conclusions: In our series, two stage hepatectomy among patients with colorectal cancer and liver metastasis, but its long term results must be evaluated.


Introducción: La hepatectomía en dos etapas utiliza la regeneración compensatoria del hígado tras una primera hepatectomía no curativa para lograr una resección curativa en una segunda intervención. Objetivo: Presentar nuestra experiencia inicial aprovechando esta propiedad, en la estrategia de manejo de pacientes previamente declarados irresecables. Material y Método: Entre Marzo de 2006 y Marzo de 2010, fueron tratados 8 casos. Resultados: De 64 pacientes en los que se realizó hepatectomía, 8 de ellos, con enfermedad metastásica bilateral, confinada al hígado, fueron sometidos a ligadura portal del lado derecho; en la mitad se realizó resección simultánea de enfermedad del futuro remanente hepático izquierdo. Cuatro a 8 semanas más tarde, cinco fueron sometidos a hepatectomía derecha extendida o hepatectomía derecha (con segmento IV previamente resecado), y otro que era recurrente de previa hepatectomía central más colectomía, fue explorado, ligado y luego sometido a cirugía combinada con radiofrecuencia (RFA). Con seguimiento promedio para el grupo resecado RO (n = 6) de 18 meses (3-39), una paciente fallece por recurrencia pulmonar masiva a los 18 meses del diagnóstico, dos se someten a tercera cirugía y RFA con intención curativa, sin evidencia actual de enfermedad, dos no presentan recurrencia y una presenta recurrencia costal, sin evidencia de enfermedad intraabdominal. Otros dos están esperando la hepatectomía post resección del primario y ligadura portal. Conclusión: En nuestro medio, la colectomía y hepatectomía en múltiples etapas en pacientes con enfermedad hepática bilateral metastásica de origen colorrectal es una estrategia factible y razonable para lograr una resección con intención curativa.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Hepatectomy/methods , Colorectal Neoplasms/pathology , Liver Neoplasms/surgery , Liver Neoplasms/secondary , Colectomy , Ligation , Colorectal Neoplasms/surgery , Portal Vein/surgery
2.
Rev. méd. Chile ; 123(2): 165-75, feb. 1995. tab, ilus
Article in Spanish | LILACS | ID: lil-151169

ABSTRACT

Tyrosine protein kinase (TPK) activity is associated to malignant cellular transformation. This work compares TPK activity in 27 surgical biopsy samples of mammary carcinoma, 10 samples of normal mammary tissue. TPK activity was determined in tissue homogenates using (Val5) angiotensin II as exogenous substrate. In samples of mammary carcinoma, TPK activity was 33.86 ñ 31.98 pmol P32/mg protein/30 min. This value was significantly higher that those observed in fibrocystic disease (3.92 ñ 2.35), fibroadenomas (13.86 ñ 10.9) and normal tissue (3.56 ñ 3.02)


Subject(s)
Humans , Female , Adult , Middle Aged , Protein-Tyrosine Kinases/biosynthesis , Breast Neoplasms/enzymology , Breast/enzymology , Breast Diseases/enzymology , Carcinoma/enzymology , Case-Control Studies , Fibroadenoma/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL